Recent data from Hong Kong's stock exchange reveals that on July 16th, J.P. Morgan increased its stake in Asymchem Laboratories (Tianjin) Co., Ltd. (SEHK: 06821). The transaction involved the purchase of 185,950 shares at a price of HK$130.859 per share, amounting to a total investment of approximately HK$24.33 million.
Following this acquisition, J.P. Morgan's total shareholding in the company has risen to about 2.3471 million shares. This new position represents approximately 8.43% of the company's issued shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments